成瀬 寛之

Medicine & Life Sciences

1. Acute Coronary Syndrome 72%
2. Acute Kidney Injury 36%
3. Angioscopy 32%
4. Area Under Curve 22%
5. Atherosclerotic Plaques 16%
6. Atrial Fibrillation 22%
7. Biomarkers 25%
8. Brain Natriuretic Peptide 100%
9. Computed Tomography Angiography 84%
10. Coronary Artery Disease 49%
11. Coronary Vessels 41%
12. Coronavirus 35%
13. Drug-Eluting Stents 24%
14. Eicosapentaenoic Acid 25%
15. Fatty Acid Binding Protein 3 15%
16. Fatty Acid-Binding Proteins 26%
17. fibrin fragment D 31%
18. Glomerular Filtration Rate 15%
19. Heart Failure 70%
20. Hemorrhage 15%
21. human FABP3 protein 20%
22. Hydroxymethylglutaryl-CoA Reductase Inhibitors 21%
23. Intensive Care Units 17%
24. iodofiltic acid 31%
25. Japan 21%
26. LDL Cholesterol 16%
27. Lipids 16%
28. Mortality 30%
29. Myocardial Infarction 33%
30. Myocardial Perfusion Imaging 27%
31. No-Reflow Phenomenon 15%
32. Non-ST Elevated Myocardial Infarction 29%
33. Optical Coherence Tomography 30%
34. Pathologic Constriction 26%
35. Percutaneous Coronary Intervention 35%
36. pitavastatin 25%
37. PTX3 protein 15%
38. Rivaroxaban 27%
39. Sarcoidosis 22%
40. Serum 34%
41. Severe Acute Respiratory Syndrome 15%
42. Sirolimus 24%
43. ST Elevation Myocardial Infarction 17%
44. Stents 47%
45. Stroke Volume 25%
46. Tomography 29%
47. Troponin I 25%
48. Troponin T 60%
49. Unstable Angina 31%
50. Vaccines 16%